Transaction with Philips approved by SHL shareholders. SHL is to receive around USD 110 million as upfront cash consideration and debt
assumption.

Closing of transaction with Philips has been scheduled for November 30th

Prof. Dr. med Klaus Pethig is a renowned expert in cardiac catheter treatments and cardiological intensive care and is currently the head of the cardiological department of the Evangelische Krankhaus Hamm.

of SHL’s Raytel Cardiac Services into Philips.
Tel Aviv/Zurich, 30 October 2007 - SHL Telemedicine Ltd. (SWX: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, announces that it has been advised by the Pre merger Notification Office of the US Federal Trade Commission that early termination of the U.S. Antitrust Waiting Period has been granted thereby clearing the sale of Raytel Cardiac Services and other ancillary operations comprising SHL's US cardiac monitoring activities to Royal Philips Electronics (NYSE:PHG, AEX:PHI).

regarding transaction with Philips on 27 November 2007

including the distribution by Philips of SHL telemedicine products in North America

SHL Telemedicine's results for Q2 in line with expectations. SHL expects to announce significant transaction regarding its US business in coming days.

Tel Aviv/Zurich, 24 September 2007 - SHL Telemedicine Ltd. (SWX: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, will now publish its half-year results on 1 October 2007.

ON NEW STATE-OF-THE ARTWIRELESS
First in a family of unique devices to assist physicians in diagnosing and managing cardiac arrhythmias